穴位贴敷疗法干预矮小症现代文献分析

doi:10.20223/j.cnki.1000-8535.2025.02.018

摘要/Abstract

摘要： 目的分析现代文献中穴位贴敷疗法干预矮小症研究现状,为临床治疗该病提供依据。方法整理近2018年1月—2023年12月6年间国内医学期刊上公开发表的关于穴位贴敷疗法治疗矮小症的中文文献,对文献年代分布、发表期刊、研究内容、贴敷穴位、贴敷药物、贴敷的时间、频次、治疗时间、观察指标、中西医结合治疗矮小症、不良反应等进行统计分析。结果最终纳入的文献共10篇,近6年间均有相关文献发表;发表期刊《中医儿科杂志》《新中医》《中国现代医生》《中医外治杂志》《中国中西医结合儿科学》;研究内容涉及矮小症分型、穴位贴敷联合重组人生长激素法、畲医法、中药内服法、拉伸操法、营养干预指导、推拿等方法治疗矮小症。结论穴位贴敷疗法联合其他疗法在临床上对儿童矮小症的改善效果显著,不良反应轻微,相信随着矮小症成因的进一步明确,穴位贴敷疗法治疗矮小症的机制会更加清晰,为改善矮小症提供科学理论依据,同时,为矮小症等相关疾病的治疗提供新思路。

关键词: 中医, 儿童, 矮小症, 穴位贴敷

Abstract: Objective To analyze the research status of acupoint application therapy in short stature from January 2018 to December 2023,and to provide basis for clinical treatment of the disease. Methods To review the Chinese literature published in domestic medical journals in recent 6 years on the treatment of short stature by acupoint application therapy,including the distribution of time and journals,the research contents,the acupoint application,the drug application,the application time,the treatment frequency and duration,the observation index,treatment of short stature with integrated traditional,Chinese and Western medicine and adverse reactions were statistically analyzed. Results There were 10 articles in this review,and all of them were published in the past 6 years,published journal were Pediatrics of Traditional Chinese medicine,new Traditional Chinese medicine,modern Chinese doctor,Journal of external treatment of traditional Chinese medicine,Pediatrics of integrated traditional Chinese and Western medicine in China．The research content involved the short stature classification,acupoint application combined with recombinant human growth hormone therapy,the She medical therapy,traditional Chinese medicine,stretching manipulation,nutrition intervention guidance,massage and other methods. Conclusions The combination of acupoint application therapy and other therapies has a significant clinical effect on the improvement of short stature in children,with slight adverse reactions．It is believed that with the further clarification of the causes of short stature,the mechanism of point application therapy for short stature will be more clear and provide scientific basis for improving short stature．At the same time,it may provide a new idea for the treatment of dwarfism and other related diseases．

Key words: Chinese medicine, children, short stature, acupoint application

谢红颖, 黄伟. 穴位贴敷疗法干预矮小症现代文献分析[J]. 广州医药, 2025, 56(2): 260-267.

XIE Hongying, HUANG Wei. Modern literature analysis of acupoint application therapy for short stature[J]. Guangzhou Medical Journal, 2025, 56(2): 260-267.

参考文献

[1] 宋鹏,夏桂选.中医治疗矮小症临床文献分析[J].中国中西医结合儿科学,2015,7(4):323-325.
[2] 中华医学会儿科学分会内分泌遗传代谢学组.矮身材儿童诊治指南[J].中华儿科杂志,2008,46(6):428-430
[3] 张建. 浅析中医治疗身材矮小之难[J].中医学报,2013,28(8):1155-1156.
[4] 刘锋,杨雯轩,刘乾生,等.矮身材儿童中医治疗研究进展[J].中国中西医结合儿科学,2020,12(2):128-131.
[5] 冯冰,马丽霞,曲敬师,等.中医药治疗儿童特发性矮小效果评价[J].社区医学杂志,2013,11(13):31-32.
[6] 刘静,吴耀持.中药穴位贴敷的临床应用现状及机制探讨[J].上海医药,2018,39(24):3-5.
[7] 褚珺琼,戴桂芬.中药穴位贴敷联合重组人生长激素治疗矮小症患儿26例临床观察[J].中医儿科杂志,2018,14(5):56-58.
[8] 朱灵芝,茹锦岩,俞慧君,等.儿童生长贴联合重组人生长激素治疗特发性矮小症的疗效[J].中国现代医生,2019,57(10):59-61,65.
[9] 叶亚云,金掌,鄢连和,等.畲医法小儿生长发育贴治疗土虚木亢体质儿童特发性矮身材临床疗效[J].中国现代医生,2019,57(13):71-74.
[10] 蔡成思,王爱敏.中药辨证内服联合穴位贴敷治疗特发性矮小症临床研究[J].新中医,2020,52(20):71-73.
[11] 沈晓敏,姚芳园,沈贤新,等.儿童生长贴联合艾灸、运动操及饮食习惯调整对儿童身高改善的影响[J].新中医,2021,53(5):175-178.
[12] 汪建伟,王丹晶,罗群燕,等.儿童生长贴联合儿童拉伸操对特发性矮身材儿童身高影响[J].中国现代医生,2019,57(6):79-82,86.
[13] 马金苹,丁玫芳,倪毅.中医生长贴联合训练操治疗特发性矮小症临床研究[J].新中医,2022,54(22):152-155.
[14] 吴爱惜,陈玲娇,冯海英.生长贴联合营养干预指导对儿童生长发育及营养状况的影响[J].中国现代医生,2021,59(1):61-64.
[15] 贺玉英. 特制生长贴联合推拿治疗儿童矮身材的疗效观察[J].中医外治杂志,2023,32(1):62-63.
[16] 宋艳玲,况琦,王晓鸣,等.健儿助长贴治疗身材偏矮儿童脾肾两虚证的临床疗效观察[J].中国中西医结合儿科学,2023,15(4):365-368.
[17] 刘芳,杨翠.四君子汤、推拿联合重组人生长激素对矮小症患儿生长发育的影响[J].湖北中医杂志,2021,43(8):11-13.
[18] KLINGSEISEN A,JACKSON A P.Mechanisms and pathways of growth failure in primordial dwarfism[J].Genes Dev,2011,25(19):2011-2024.
[19] RHEE E J,CHO J H,KWON H,et al.Relation between baseline height and new diabetes development:A nationwide population-based study[J]. Diabetes Metab J,2019,43(6):794-803.
[20] GJÆRDE L K,TRUELSEN T C,BAKER J L.Childhood stature and growth in relation to first ischemic stroke or intracerebral hemorrhage[J].Stroke,2018,49(3):579-585.
[21] Emerging Risk Factor Collaboration.Adult height and the risk of cause-specific death and vascular morbidity in 1 million people:Individual participant meta-analysis[J].Int J Epidemiol,2012,41(5):1419-1433.
[22] 张建. 关于中医学“矮小症”的定义思考[J].中国中西医结合儿科学,2013,5(3):213-214.
[23] 张佳娟,叶进.叶进从小儿脾虚质论治矮小症经验[J].浙江中医药大学学报,2017,41(1):72-74.
[24] 段娟. 儿童矮小症的中医临床辨治思路[J].四川中医,2022,40(10):34-37.
[25] 陈祺,宣桂琪.宣桂琪辨治特发性矮小症之精粹[J].江苏中医药,2011,43(4):17-18.
[26] 孙凤平,韩雪,崔伟锋,等.从肝肾脾胃论治特发性矮身材之我见[J].中医临床研究,2017,9(3):13-15.
[27] 孔蕊. 中西医结合综合治疗对特发性矮小症(ISS)患儿的临床疗效[J].首都食品与医药,2019,26(6):35-36.
[28] 刘琦,耿晓桐,花娇娇,等.茯苓化学成分及药理作用研究进展[J].品牌与标准化,2023(2):106-109.
[29] 肖先,李春燕,刘晓龙,等.甘草的主要化学成分及药理作用研究进展[J].新乡医学院学报,2023,40(3):280-285.
[30] 张晗,张磊,刘洋.龙骨、牡蛎化学成分、药理作用比较研究[J].中国中药杂志,2011,36(13):1839-1840.
[31] 张柂儇,刘海龙,王瑞琼,等.黄芪化学成分和药理作用及Q-marker预测分析[J].中国新药杂志,2023,32(4):410-419.
[32] 李力恒,陈昌瑾,胡晓阳,等.党参的化学成分及药理作用研究进展[J].中医药学报,2023,51(3):112-115.
[33] 谢佳宏,韩淑丽.中药穴位贴敷近5年临床应用概况[J].中国临床医生杂志,2015,43(4):26-28.
[34] LIU Y,YAO L,YAN B,et al.The effectiveness of acupoint application of traditional Chinese medicine in treating primary dysmenorrhea:A protocol for meta-analysis and data mining[J].Medicine 2021,100(24):e26398.
[35] 朱宝,宋瑞平,张彦军.中药穴位贴敷疗法的理论与机制探讨[J].甘肃医药,2016,35(8):578-580.
[36] TIDBLAD A,BOTTAI M,KIELER H,et al.Association of childhood growth hormone treatment with long-term cardiovascular morbidity[J].JAMA Pediatr,2021,175(2):e205199.
[37] 葛丽萍,赵灿淼,许芳,等.聚乙二醇重组人生长激素治疗儿童特发性矮小症的研究进展[J].现代临床医学,2023,49(2):128-130.
[38] WANG C,HUANG H,ZHAO C,et al.The impact of pegylated recombinant human growth hormone replacement therapy on glucose and lipid metabolism in children with growth hormone deficiency[J].Ann Palliat Med,2021,10( 2):1809-1814.
[39] GHOSH S,CHAKRABORTY P P,BANKURA B,et al.Different growth responses to recombinant human growth hormone in three siblings with isolated growth hormone deficiency type 1a due to a 6.7 Kb deletion in the GH1 gene[J].J Clin Res Pediatr Endocrinol,2021,13( 4):456-460.
[40] 张钰沁,林莉.中医理论体系下西药的运用—西药中药化的方法探究[J].广州医药,2024,55(1):99-105.
[41] 冯斌,张超.金匮肾气丸配合rhGH对特发性矮小症患儿生长速度及其相关生化指标血清水平的影响观察[J].时珍国医国药,2020,31(8):1852-1854.
[42] 曾敏. 健脾助长汤联合重组人生长激素治疗特发性矮小症的疗效及对患儿血清IGF-1、Ghrelin的影响[J].内蒙古中医药,2024,43(2):54-56.
[43] 史润朦,吴文先,田丽.异功散加味辅助重组人生长激素对特发性矮小症患儿骨代谢及血清Omentin-1、FGF-21水平的影响[J].国医论坛,2024,39(2):30-33.
[44] 史航,刘双军,许照洁.调中保元汤加味联合重组人生长激素治疗儿童特发性矮小症33例[J].中国中医药科技,2023,30(6):1223-1225.
[45] 吴楚婷,曾维礼,刘湘.探讨不同年龄儿童性早熟影响因素及预防措施[J].广州医药,2021,52(4):10-13,19.
[46] 林泽锋,郭予涛,林海鹏,等.汕头地区儿童矮小症127例临床分析[J].现代医院,2021,21(11):1788-1790.